Validation of the DLQI questionnaire in assessing the disease burden and principal aspects related to life quality of vitiligo patients
- PMID: 38873521
- PMCID: PMC11171417
- DOI: 10.3389/fpsyg.2024.1333723
Validation of the DLQI questionnaire in assessing the disease burden and principal aspects related to life quality of vitiligo patients
Abstract
According to many studies, vitiligo has a negative psychological influence on the patient's life. Multiple factors contribute to the severity of the vitiligo disease burden, among which the most important are self-esteem, stress, and stigma. We aimed to measure the importance of health-related life quality in assessing disease burden in patients with vitiligo. We formulated an HA, which is the principal hypothesis, claiming a single fundamental factor that characterizes the life quality of patients with vitiligo. We also formulated 10 important research questions related to the quality of life that can be generally formulated for patients with dermatological illnesses but particularly suited for vitiligo patients. These research questions capture fundamental aspects of the health-related quality of life of vitiligo patients influenced by symptoms and feelings, daily activities, leisure, job and education, personal relationships, and treatment. These also cover specific aspects related to the quality of life, such as skin-caused sexual difficulties, difficulties in social relationships, and difficulties in performing sports, among others. The Dermatology Life Quality Index (DLQI) questionnaire measures the health-related quality of life of persons suffering from skin diseases. We applied this generic questionnaire to patients with vitiligo. Following a set of inclusion and exclusion criteria, we obtained 114 carefully selected patients who responded to all the questions. This study also validated the DLQI questionnaire on persons who suffer from vitiligo. We investigated whether DLQI has acceptable internal consistency by applying Cronbach's alpha internal consistency indicator (Cα). The obtained Cα = 0.914 indicates excellent internal consistency. We also examined whether all the questions in the questionnaire were mathematically consistent, which we finally proved. It was not necessary to remove any of the questionnaire questions. To prove our HA, a Principal Axis Factoring (PAF) was applied, verifying the assumptions regarding the Average Variance Extracted (AVE) and Convergent Validity (CV). HA proved that applying PAF on DLQI resulted in extracting a single general vitiligo latent factor of life quality, with an initial eigenvalue = 5.671, SS loadings = 5.2, and 52 % of the total cumulative variance explained. Diverse statistical analyses were applied to analyze the 10 formulated research questions. The results of the analysis of the research questions are presented and discussed in the manuscript. One of the conclusions related to the analysis of a research question was that sex had the lowest correlation with the latent life quality factor identified for vitiligo patients.
Keywords: Dermatology Life Quality Index; Principal Axis Factoring; burden of vitiligo; health-related quality of life; psychometric properties of a questionnaire; symptoms and feelings; treatment; vitiligo.
Copyright © 2024 Fekete, Iantovics and Fekete.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Exploratory axis factoring for identifying the self-esteem latent factors and their correlation with the life quality of persons suffering from vitiligo.Front Psychol. 2023 Dec 15;14:1200713. doi: 10.3389/fpsyg.2023.1200713. eCollection 2023. Front Psychol. 2023. PMID: 38162970 Free PMC article.
-
Effect of vitiligo on self-reported health-related quality of life.Br J Dermatol. 2005 Jun;152(6):1165-72. doi: 10.1111/j.1365-2133.2005.06456.x. Br J Dermatol. 2005. PMID: 15948977
-
Dermatology Life Quality Index (DLQI) scores in burn victims after revival.J Burn Care Res. 2007 Mar-Apr;28(2):312-7. doi: 10.1097/BCR.0B013E318031A151. J Burn Care Res. 2007. PMID: 17351451
-
[Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].Encephale. 2003 Mar-Apr;29(2):137-47. Encephale. 2003. PMID: 14567165 Review. French.
-
Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades.Int J Dermatol. 2016 Jun;55(6):608-14. doi: 10.1111/ijd.13198. Epub 2016 Jan 8. Int J Dermatol. 2016. PMID: 26749040 Review.
Cited by
-
Comprehensive analysis of life quality of patients with vitiligo in Romania: insights from a multivariate approach.Front Med (Lausanne). 2025 May 26;12:1613083. doi: 10.3389/fmed.2025.1613083. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40491768 Free PMC article.
-
Metabolic anomalies in vitiligo: a new frontier for drug repurposing strategies.Front Pharmacol. 2025 Apr 15;16:1546836. doi: 10.3389/fphar.2025.1546836. eCollection 2025. Front Pharmacol. 2025. PMID: 40303919 Free PMC article.
References
-
- Aguilera-Durán G., Romo-Mancillas A. (2021). Behavior of chemokine receptor 6 (CXCR6) in complex with CXCL16 soluble form chemokine by molecular dynamic simulations: general protein–ligand interaction model and 3D-QSAR studies of synthetic antagonists. Life 11:346. 10.3390/life11040346 - DOI - PMC - PubMed
-
- Al-Harbi M. (2013). Prevalence of depression in vitiligo patients. Skinmed 11, 327–330. - PubMed
-
- Alikhan A., Felsten L. M., Daly M., Petronic-Rosic V. (2011). Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J. Am. Acad. Dermatol. 65, 473–491. 10.1016/j.jaad.2010.11.061 - DOI - PubMed
LinkOut - more resources
Full Text Sources